Literature DB >> 32478128

Understanding the Associations between Caregiver Characteristics and Cognitive Function of Adults with Cancer: A Scoping Review.

Yesol Yang1, Sharron Rushton2, Hyeyoung K Park3, Heeyeon Son1, Amanda Woodward4, Eleanor Mcconnell5,6, Cristina C Hendrix2,6.   

Abstract

Cognitive impairment (CI) is one of symptoms that adults with cancer frequently report. Although there are known factors that contribute to a patient's CI, these factors did not sufficiently explain its variability. Several studies conducted in patients with neurocognitive disorders have reported relationships between patients' cognitive function and caregiver characteristics, which are poorly understood in the context of cancer. This scoping review aims to map the literature on caregiver characteristics associated with CI in adults with cancer. We used the framework proposed by Arksey and O'Malley and PRISMA-Sc. Studies published in English by 2019 were searched through seven electronic databases. All retrieved citations were independently screened and eligibility for inclusion was determined by two independent authors. Ten studies met inclusion for this review with all of them showing significant associations between a patient's cognitive function and caregiver characteristics. Caregiver's mental health was the most commonly associated with a patient's cognitive function followed by family functioning, adaptation to illness, attitude toward disclosure of the illness, burden, coping and resilience, and demographic characteristics. These review findings suggest that enhanced information about CI in relation to caregiver characteristics will eventually provide the foundation for multifocal interventions for patients with impaired cognitive function. This scoping review identified caregiver characteristics that are associated with patients CI. These characteristics should be also assessed when health providers assess and treat CI of adults with cancer. Copyright:
© 2020 Ann & Joshua Medical Publishing Co. Ltd.

Entities:  

Keywords:  Caregivers; cognitive function; cognitive impairment; neoplasms; oncology; scoping review

Year:  2020        PMID: 32478128      PMCID: PMC7233557          DOI: 10.4103/apjon.apjon_3_20

Source DB:  PubMed          Journal:  Asia Pac J Oncol Nurs        ISSN: 2347-5625


Introduction

Adults with cancer need support from their informal caregivers (e.g., family or close others) to cope with their illness.[123] Caregivers of adults with cancer engaged in caregiving tasks approximately 33 h/week, which is 1.3 times higher than the number of hours spent by noncancer caregivers.[4] Caregivers of cancer patients provide a wide variety of assistance, ranging from simply providing transportation to more complex tasks such as managing medications and cancer-related symptoms.[56] Given the wide variety of tasks and time commitment, caregiving can be demanding, and there are many reports about caregiving consequences such as burden.[7] Despite the negative consequences reported to be associated with cancer caregiving, caregivers are often essential for patients with cancer to manage their care and symptoms at home.[8]

Background

Of many cancer-related symptoms, impaired cognitive function is a symptom frequently reported by adults with cancer. Cognitive symptoms manifest as a decline in at least one area of cognitive function: attention, concentration, information processing speed, memory, language, executive function, spatial ability, or psychomotor ability.[9] Patients with cognitive impairment (CI) often experience challenges in their social relationships with family or friends,[1011] quality of life,[12] and adherence to treatment.[13] Researchers have reported that CI in cancer has been associated with the disease itself, adverse effects from cancer treatments (e.g., fatigue or emotional distress), patients' age, menopause status, genetic variation, and/or level of education.[14] However, these factors do not fully explain the clinical variability of CI among cancer patients. Some patients have reported that cognitive changes that occurred during chemotherapy persisted more than a year following cancer treatments.[15] Caregiver characteristics may provide some explanation on the clinical variability in cognitive function in adults with cancer. In studies of those with neurocognitive disorders, caregiver characteristics such as burden,[161718] personality,[19] type of coping strategies they used,[2021] and closeness of relationship[22] with the patient are reciprocally associated with their patients' level of cognitive function. In their theory of dyadic illness management, Lyons and Lee[23] stated that caregiver characteristics (for examples, relationship with patient and how caregivers appraise and cope with patients' illness) are associated with the patient health outcomes.[23] In addition, evidence suggests that the degree to which caregivers have negative or positive reactions toward the care situations can affect the quality of patient care and influence the patient health outcomes[242526] such as physical and psychological distress. Several cancer studies in cancer patients have also identified the interdependence of patients and caregivers and often assessed a patient-caregiver dyad as a unit of care.[2327] More emotional and physical problems were noted among cancer patients when they received care from their caregivers with more emotional and physical problems.[252829] Although researchers have acknowledged the importance of the interrelationship of patient-caregiver as a dyad, no consensus exists regarding if (and how) caregiver characteristics are associated with cognitive function in adults with cancer. For our scoping review, we adopted the model that explained reciprocal relationship between patients' and caregivers' emotional distress, which was developed by Northouse et al.[29] This model was created based on two meta-analyses[2730] showing a positive association between patients' and caregivers' emotional distress. Although this model primarily focused on emotional distress of both groups, we modified this model to explore the associations between caregiver characteristics and cognitive function of adults with cancer. The aim of this scoping review is to address the question what caregiver characteristics are associated with cognitive function of adults with cancer? This will lay the foundation for studies that explicate the mechanism of CI in adults with cancer. Understanding the mechanism of CI in adults with cancer will also allow clinicians to more precisely identify patients at risk for CI associated with caregiver characteristics and will contribute toward the development of dyadic intervention for both patient and caregiver.

Methods

A literature search was conducted in June 2019 using seven databases, PubMed (MEDLINE), CINAHL, Embase, PsycINFO, Scopus, Sociological Abstracts, and ProQuest dissertation abstracts. Prospero, PubMed (MEDLINE), CINAHL, Embase, PsycINFO, Scopus, Sociological Abstracts, and ProQuest dissertation abstracts were searched for existing review articles and we determined that no reviews articles currently exist on a given topic. We followed the five methodological stages of scoping review developed by Arksey and O'Malley.[31] This review was conducted based on the following stages: (1) identifying the research question, (2) identifying relevant studies, (3) selecting studies, (4) charting the data, and (5) collating, summarizing, and reporting the results. A detailed methodology of this scoping review was reported in the published protocol.[32] Furthermore, the protocol was registered with Open Science Framework.[33] We identified a research question using the PCO model:[34] “What caregiver characteristics (“C”, concept) are associated with cognitive function (“O”, outcome) of adults with cancer (“P”, population)?”. Inclusion criteria were the studies that (1) assessed one or more cognitive domains of adults with cancer (e.g., attention, concentration, information processing speed, memory, language, executive function, spatial ability, and/or psychomotor ability); (2) examined the associations between caregiver characteristics and cognitive function of adults with cancer; and (3) were conducted on both adults with cancer and their caregivers aged 18 years and above. Studies that focused on individuals with CI attributed to noncancer causes such as psychiatric or neurological illness, dementia, stroke, brain injury, or delirium were excluded. The search strategy can be found in Appendix A. Of 4387 citations, 38 were identified after a title and abstract review, and eight were confirmed after a full-text review. Two additional citations were found from the reference lists of included articles [Figure 1]. A total of 10 studies were included in this scoping review. Each retrieved citation was reviewed at least twice by independent team members at title/abstract, full text, and abstraction. All discrepancies were discussed to reach consensus. The studies in the final sample were reported using the checklists of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR)[35] and tabulated based on caregiver characteristics (e.g., mental health). Studies were organized in chronological order, and data extraction included author information, publication year, study population, caregiver A chronological table was created and included the information on authors, years of publication, study population, caregiver characteristics (i.e., caregiver characteristics), cognitive measures, and its associations. At least two team members independently conducted the verification of data accuracy.
Figure 1

PRISMA-ScR flow diagram for the study selection process

PRISMA-ScR flow diagram for the study selection process

Results

Study characteristics

The studies reviewed were conducted in five countries; the majority were conducted in the in the US (n = 5) and Australia (n = 2). Of 10 studies, six were cross-sectional, three were a secondary analysis from a multiple-institutional cohort study, and one was a multiple in-depth case study. Of those three secondary analysis studies, two used the same data set.[3637] Sample sizes of all included studies ranged from 3 to 396 participants. The average age of patients reported in the studies ranged from 23.5 to 73 years of age. Of the included studies, five dealt with the group of patients with non-central nervous system (CNS) cancers followed by CNS cancer (n = 2). The remaining of two studies included both groups of patients with CNS and non-CNS (n = 2) cancers. The reported types of non-CNS cancers varied including the lung, hematologic, breast, gastrointestinal, and melanoma [Table 1].
Table 1

Study characteristics

Author (year), CountryStudy designSample (n)PatientsCG


Age, mean (SD)Education level (%): Years, mean (SD)Type of cancerAge, mean (SD)VariablesRelationship with patients (%)
Ownsworth et al. (2009)[1], AustraliaCross-sectional(63) CG of patients with brain tumor and other cancers≥18 yearsNRBrain tumor and other cancersCG of patients with brain tumor: 56.93 (12.34)CG of patients with others: 62.47 (10.67)DepressionCG of patients with brain tumor Spouse/partner: 85.2% Parent: 11.1% Child: 3.7% Sibling: 0%CG of patients with other cancer Spouse/partner: 91.7% Child: 5.5% Sibling: 2.8%
Ownsworth et al. (2010)[2], AustraliaCross-sectional(63) CG of patients with brain tumor and other cancers≥18 yearsNRBrain tumor and other cancers60.1 (11.7)Psychological well-beingSpouse/partner: 88.8%
Hocking et al. (2011)[3], USAMultiple, in-depth case study(3) adults survivors with childhood brain tumors and mothers19 years24 years26 yearsNR; College graduate; specialized high school graduateBrain tumorNRFamily functioning, perceived demands, and QOLMother: 100%
Boele et al. (2013)[4], NetherlandSecondary analysis(396) CG of patients with LGG, NHL/CLL, HGG, and NSCLC≥18 yearsNRLGG, NHL/CLL, HGG, and NSCLCCG of patients with LGG: 45.27 (11.94)CG of patients with NHL/CLL: 52.96 (11.94) CG of patients with HGG: 53.31 (11.43) CG of patients with NSCLC: 57.23 (11.75)Mental healthCG of patients with LGGSpouse/partner: 71.4% Parent: 11.3% Child: 2.3% Sibling: 1.4% Friend: 0.9%CG of patients with NHL/CLL Spouse/partner: 90.9% Sibling: 2.0% Parent: 1.0% Child: 1.0% Friend: 1.0%CG of patients with HGG Spouse/partner: 78.2% Friend: 10.9% Parent: 3.6% Sibling: 1.8% Child: 0%CG of patients with NSCLC Spouse/partner: 86.2% Child: 6.9% Sibling: 3.4% Friend: 0% Parent: 0%
Gao et al. (2013)[5], USASecondary analysis(221) patients with advanced cancer and their CG59.5 (12.4)12.4 (3.8)Lung, colon, pancreatic, other gastrointestinal, breast, and other51.4 (14.1)Demographic: race/ethnicity and relationship with patientsSpouse/partner: 47.8%Child: 26.3%Other: 25.9%
Meyer et al. (2013)[6], USASecondary analysis(356) patients with advanced cancer and their CG≥20 yearsNRLung, colon, pancreatic, other gastrointestinal, breast, and otherNRPreloss mental healthSpouse/partner and others
Kim et al. (2014)[7], KoreaCross-sectional(136) patients with advanced cancer and their family CG56 (median)High school or less: 86.3%College or over: 13.7%Lung, stomach, colon/rectum, breast, esophagus, and others52 (median)Attitude toward disclosureSpouse/partner: 61.2%Parents or offspring: 29.8%Other family members: 9%
Hocking et al. (2015)[8], USACross-sectional(34) brain tumor survivors and their mothers23.53 (3.36)NRBrain tumor53.74 (5.67)Family functioningMother: 100%
Libert et al. (2017)[9], BelgiumCross-sectional(166) patients with hematologic malignancies≥65 yearsJunior high school or less: 63%High school graduation or more: 37%Hematologic malignanciesNRBurdenNR
Saria et al. (2017)[10], USACross-sectional(56) CG of patients with brain metastases>18 yearsNRBreast, lung, melanoma, and other cancers56.3 (14.9)Coping and ResilienceSpouse: 67.9% Son/daughter: 16.1%Parent: 5.3%Brother/sister: 3.6%Son-in-law/daughter-in-law: 1.8%

LGG: Low-grade glioma, NHL/CLL: Non-Hodgkin lymphoma/chronic lymphatic leukemia, HGG: High-grade glioma, NSCLC: Non-small-cell lung cancer, QOL: Quality of life, SD: Standard deviation, NR: Not reported, CGs: Caregivers

Study characteristics LGG: Low-grade glioma, NHL/CLL: Non-Hodgkin lymphoma/chronic lymphatic leukemia, HGG: High-grade glioma, NSCLC: Non-small-cell lung cancer, QOL: Quality of life, SD: Standard deviation, NR: Not reported, CGs: Caregivers

Caregiver characteristics and the associations with a patient's cognitive function

Caregiver mental health is defined as an optimal level of emotional/psychological functioning, wherein caregivers report no caregiving-related stress.[38] Four studies examined the associations between a caregiver's mental health and a patient's cognitive function [Table 2]. These studies found that a caregiver's mental health was associated with cognitive function of adults with cancer.[36383940] Patients with nonbrain tumors (e.g., lung or breast) showed greater CI when their caregivers had poorer overall psychological well-being (r = 0.46, P < 0.005),[38] and were more depressed (r = −0.40, P < 0.005).[39] However, among brain tumor patients, no associations were identified between a caregiver's depression and cognitive function of a patient diagnosed with brain tumor.[39] In comparison, in the total caregiver sample (caregivers of patients with brain tumor and nonbrain cancers), greater CI was observed among patients who received care from caregivers with poorer overall psychological well-being (r = 0.38, P < 0.005).[38]
Table 2

Characteristics of studies regarding caregiver variables in relation to the Patient’s cognitive function

Author (year)Sample (n)CG variablesCognitive domains (measures)Analysis adjust forKey findings
Mental health
 Ownsworth et al. (2009)[1]63 CGs of patients with brain cancer (27) and other cancers (36)Depression assessed by DASSSubjective cognitive deficits (PCRS)Patients’ cancer type and CGs’ genderIn other cancer groups, patients’ cognitive function was significantly associated with the level of CGs’ depression (r=−0.40, P<0.05), but no association in the brain cancer group
 Ownsworth et al. (2010)[2]63 CGs of patients with brain cancer (27) and other cancers (36)Psychological well-being assessed by WHOQOL-BREFSubjective cognitive deficits (PCRS)CGs’ genderIn other cancer groups, patients’ cognitive function was significantly associated with CGs’ psychological well-being (r=0.46, P<0.005) In brain cancer group, patients’ cognitive function was not associated with CGs’ psychological well-being In total CG sample, patients’ cognitive function was significantly associated with CGs’ psychological well-being (r=0.38, P<0.005)
 Boele et al. (2013)[4]396 significant others of patients with LGG (213), NHL/CLL (99), HGG (55), and NSCLC (29)Mental health assessed by MCS of SF-36 health surveySubjective cognitive functioning (MOS subjective cognitive scale)Overall cognitive function (assessed by both objective neuropsychological testing and self-report questionnaires)CGs’ age and education levelPatients’ subjective cognitive functioning exhibited a significant association with mental health of significant others with HGG (r2=0.050, P=0.090)Patients’ cognition was associated with mental health of significant others with NSCLC (r2=−0.363, P=0.019)
 Meyer et al. (2013)[6]356 patients with advanced cancer and their CGsMental health assessed by the structured clinical interview for DSM-IV disordersSubjective cognitive functioning (SPMSQ)Patients’ white race and self-efficacyPatients’ cognitive deficits were significantly associated with their CGs’ preloss MDD (OR=6.88, P=0.02)
Family functioning
 Hocking et al. (2011)[3]3 adults survivors with childhood brain tumors and their mothersFamily functioning assessed by FAD GFS and semi-structured qualitative interviewsWorking memory (digit span, letter-number sequencing) Processing speed (WAIS-IV)Verbal learning and memory (CVLT-II)Executive function (TMT, tower test from D-KEFS, and self-reportversion of the BRIEF-A)N/ACase 1: Patient’s cognitive functioning is overall intact, and her mother also reported good levels of family functioningCase 2: Patient showed significant cognitive deficits, and both patient and her mother reported moderate difficulties related to family functioningCase 3: Patient showed cognitive deficits, and both patient and his mother reported positive family functioning
 Hocking et al. (2015)[8]34 pediatric brain tumor survivors and their mothersFamily functioning assessed by FAD and PEDS QL family impact moduleWorking memory (digit span, letter-number sequencing)Processing speed (WAIS-IV)Verbal learning and memory (CVLT-II)Executive function (TMT, D-KEFS)NRPoorer neurocognitive outcomes in brain tumor survivors were associated with worse survivor-reported family function (r=0.35-0.53, P<0.01)Poorer neurocognitive outcomes in brain tumor survivors were associated with worse mother-reported family function (r=0.39-0.55, P<0.01)
Adaptation to the patient’s illness
 Hocking et al. (2011)[3]3 adults survivors with childhood brain tumors and their mothersAdaptation to the patient’s illness assessed by semi-structured qualitative interviewsWorking memory (digit span, letter-number sequencing)Processing speed (WAIS-IV)Verbal learning and memory (CVLT-II)Executive function (TMT, tower test from D-KEFS, and self-reportversion of the BRIEF-A)N/ACase 1: Patient’s neurocognitive functioning is overall intact, and her mother showed a positive adaptation to the patient’s illnessCase 2: Patient showed limited cognitive function, and her mother endorsed difficulties in adapting to the patient’s illnessCase 3: Patient demonstrated significant cognitive deficits but positive family adaptation to the illness was reported by his mother
Attitude toward disclosure to the patient’s illness
 Kim et al. (2014)[7]136 patients with advanced cancer and their familyCGsFamily CGs’ attitude toward disclosure assessed by asking questions authors developedSubjective cognitive functioning (EORTC QLQ-C30)NRPatients’ cognitive function was associated with familyCGs’ positive attitude toward disclosure of disease progression (P=0.02)
Burden
 Libert et al. (2017)[9]166 patients with hematologic malignanciesBurden assessed using a proxy measure of CG burden (100-mm VAS)Subjective cognitive functioning (fact-cog)NRPatients’ perceived cognitive impairment was associated with patient’s self-perceived burden to their primary CGs (β=0.211, P=0.004)
Coping and resilience
 Saria et al. (2017)[10]56 CGs of patients with brain metastasis from solid tumorsCoping assessed by cope inventoryResilience assessed by resilience scaleMemory (RMBC)NRLess occurrence of memory problems was found in patients with cancer when their CGs used acceptance coping (r=0.31, P<0.05)The occurrence of memory problems was negatively associated with CGs’ resilience (r=−0.30, P<0.05)
Demographic characteristics
 Gao et al. (2013)[5]221 patients with advanced cancer and their CGsDemographic characteristics: Race/ethnicity and relationship with each patientSubjective cognitive functioning (SPMSQ)NRGreater cognitive impairment was associated with patients who had nonwhite CGs (black: OR=2.06, P<0.04; Hispanic: OR=6.31, P<0.001) and CGs who were not a spouse/partner (child: OR=2.04, P=0.04)

LGG: Low-grade glioma, NHL/CLL: Non-Hodgkin lymphoma/chronic lymphatic leukemia, HGG: High-grade glioma, NSCLC: Non-small-cell lung cancer, DASS: Depressive symptom anxiety stress scale, WHOQOL-BREF: World health organization quality-of-life scale, MCS: Mental component summary, SF-36: Short form-36, FAD GFS: General functioning scale from family assessment device, QOL: Quality of life, PEDS QL: Pediatric quality of life inventory, VAS: Visual analogue scale, PCRS: Patient competency rating scale, MOS: Medical outcome survey, SPMSQ: Short portable mental status questionnaire, CVLT-II: California verbal learning test-second edition, TMT: Trail making test, D-KEFS: Delis-Kaplan executive function, BRIEF-A: Behavior rating inventory of executive function - Adult, WAIS-IV: Wechsler adult intelligence scale-fourth edition, EORTC QLQ-C3: European organization for research and treatment of cancer QOL questionnaires, RMBC: Revised memory and behavioral problem checklist, N/A: Not applicable, NR: Not reported, MDD: Major depressive disorder, CGs: Caregivers, OR: Odds ratio, DSM-IV: Diagnostic and statistical manual of mental disorders-IV

1. Ownsworth T, Henderson L, Chambers S, Shum D. Functional impairments and caregiver depressive symptoms in the context of brain tumour and other cancers: A mediating effect of strain. Brain Impairment 2009;10:149-61.

2. Ownsworth T, Henderson L, Chambers SK. Social support buffers the impact of functional impairments on caregiver psychological well-being in the context of brain tumor and other cancers. Psychooncology 2010;19:1116-22.

3. Hocking MC, Hobbie WL, Deatrick JA, Lucas MS, Szabo MM, Volpe EM, et al. Neurocognitive and family functioning and quality of life among young adult survivors of childhood brain tumors. Clin Neuropsychol 2011;25:942-62.

4. Boele FW, Heimans JJ, Aaronson NK, Taphoorn MJ, Postma TJ, Reijneveld JC, et al. Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: A comparative study. J Neurooncol 2013;115:87-94.

5. Gao X, Prigerson HG, Diamond EL, Zhang B, Wright AA, Meyer F, et al. Minor cognitive impairments in cancer patients magnify the effect of caregiver preferences on end-of-life care. J Pain Symptom Manage 2013;45:650-9.

6. Meyer F, Zhang B, Gao X, Prigerson HG. Associations between cognitive impairment in advanced cancer patients and psychiatric disorders in their caregivers. Psychooncology 2013;22:952-5.

7. Kim S, Ko Y, Kwon S, Shin DY, Kim CH, Yang SH, et al. Family caregivers' awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer. Psychooncology 2014;23:1300-6.

8. Hocking MC, Hobbie WL, Deatrick JA, Hardie TL, Barakat LP. Family functioning mediates the association between neurocognitive functioning and health-related quality of life in young adult survivors of childhood brain tumors. J Adolesc Young Adult Oncol 2015;4:18-25.

9. Libert Y, Borghgraef C, Beguin Y, Delvaux N, Devos M, Doyen C, et al. Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: An exploratory study. Psychooncology 2017;26:118-24.

10. Saria MG, Courchesne N, Evangelista L, Carter J, MacManus DA, Gorman MK, et al. Cognitive dysfunction in patients with brain metastases: Influences on caregiver resilience and coping. Support Care Cancer 2017;25:1247-56.

Characteristics of studies regarding caregiver variables in relation to the Patient’s cognitive function LGG: Low-grade glioma, NHL/CLL: Non-Hodgkin lymphoma/chronic lymphatic leukemia, HGG: High-grade glioma, NSCLC: Non-small-cell lung cancer, DASS: Depressive symptom anxiety stress scale, WHOQOL-BREF: World health organization quality-of-life scale, MCS: Mental component summary, SF-36: Short form-36, FAD GFS: General functioning scale from family assessment device, QOL: Quality of life, PEDS QL: Pediatric quality of life inventory, VAS: Visual analogue scale, PCRS: Patient competency rating scale, MOS: Medical outcome survey, SPMSQ: Short portable mental status questionnaire, CVLT-II: California verbal learning test-second edition, TMT: Trail making test, D-KEFS: Delis-Kaplan executive function, BRIEF-A: Behavior rating inventory of executive function - Adult, WAIS-IV: Wechsler adult intelligence scale-fourth edition, EORTC QLQ-C3: European organization for research and treatment of cancer QOL questionnaires, RMBC: Revised memory and behavioral problem checklist, N/A: Not applicable, NR: Not reported, MDD: Major depressive disorder, CGs: Caregivers, OR: Odds ratio, DSM-IV: Diagnostic and statistical manual of mental disorders-IV 1. Ownsworth T, Henderson L, Chambers S, Shum D. Functional impairments and caregiver depressive symptoms in the context of brain tumour and other cancers: A mediating effect of strain. Brain Impairment 2009;10:149-61. 2. Ownsworth T, Henderson L, Chambers SK. Social support buffers the impact of functional impairments on caregiver psychological well-being in the context of brain tumor and other cancers. Psychooncology 2010;19:1116-22. 3. Hocking MC, Hobbie WL, Deatrick JA, Lucas MS, Szabo MM, Volpe EM, et al. Neurocognitive and family functioning and quality of life among young adult survivors of childhood brain tumors. Clin Neuropsychol 2011;25:942-62. 4. Boele FW, Heimans JJ, Aaronson NK, Taphoorn MJ, Postma TJ, Reijneveld JC, et al. Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: A comparative study. J Neurooncol 2013;115:87-94. 5. Gao X, Prigerson HG, Diamond EL, Zhang B, Wright AA, Meyer F, et al. Minor cognitive impairments in cancer patients magnify the effect of caregiver preferences on end-of-life care. J Pain Symptom Manage 2013;45:650-9. 6. Meyer F, Zhang B, Gao X, Prigerson HG. Associations between cognitive impairment in advanced cancer patients and psychiatric disorders in their caregivers. Psychooncology 2013;22:952-5. 7. Kim S, Ko Y, Kwon S, Shin DY, Kim CH, Yang SH, et al. Family caregivers' awareness of illness and attitude toward disclosure during chemotherapy for advanced cancer. Psychooncology 2014;23:1300-6. 8. Hocking MC, Hobbie WL, Deatrick JA, Hardie TL, Barakat LP. Family functioning mediates the association between neurocognitive functioning and health-related quality of life in young adult survivors of childhood brain tumors. J Adolesc Young Adult Oncol 2015;4:18-25. 9. Libert Y, Borghgraef C, Beguin Y, Delvaux N, Devos M, Doyen C, et al. Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: An exploratory study. Psychooncology 2017;26:118-24. 10. Saria MG, Courchesne N, Evangelista L, Carter J, MacManus DA, Gorman MK, et al. Cognitive dysfunction in patients with brain metastases: Influences on caregiver resilience and coping. Support Care Cancer 2017;25:1247-56. Two studies supported the association between a caregiver's mental health and cognitive function of adults with cancer.[3640] Adults with high-grade glioma and non-small-cell lung cancer reported decline in their subjective cognitive functioning (r2 = 0.050, P = 0.090) and overall cognition (r2 = 0.363, P = 0.019), respectively, when their significant others (i.e., caregivers) exhibited poor mental health.[40] Consistent with this finding, cognitive function of adults with advanced cancer showed the associations between their caregivers' preloss mental health.[36] For example, significant CI was found among the patients whose caregivers had major depressive disorder (MDD) (odds ratio [OR] 6.88, P = 0.02). However, among those attending bereaved caregiver groups, no associations were found between a patient's CI and a caregiver's postloss MDD. Family functioning is defined as mutuality/closeness of the relationship within a family environment.[41] The associations between a patient's cognitive function and family functioning was described in two studies[4243] [Table 2]. Hocking et al.[42] conducted an intensive case analysis using quantitative measures and qualitative interviews obtained from three dyads of adult survivors with childhood brain tumors and their mothers. Of these, one patient demonstrated intact cognition, but the other two did not. The patient with intact cognition reported good levels of family functioning and so did her mother. However, one of two patients with CI expressed conflicts among family, and her mother also endorsed negative family functioning. Interestingly, this was contradicted by the last patient with CI. He showed significant CI across all domains, but data obtained from both the patient and his mother suggested positive family functioning. Another study conducted on 34 patient-caregiver dyads also indicated that worse patient-reported family functioning was associated with their poorer processing speed (r = −0.42, P < 0.05), working memory (r = −0.35, P < 0.05), long-term verbal memory (r = −0.35, P < 0.05), and executive function (r = −0.39, P < 0.05), respectively.[43] A similar pattern of the associations was noted between a patient's cognitive function and mother-reported family functioning. A poor family functioning reported by mothers was significantly associated with a patient's poor processing speed (r = 0.55, P < 0.01), working memory (r = 0.39, P < 0.01), long-term verbal memory (r = 0.43, P < 0.01), mental flexibility (r = 0.55, P < 0.01), and executive function (r = 0.39, P < 0.01). Family adaptation reflects the process of how family members adjust or accommodate their roles and responsibilities to various stressors such as the patient's illness.[44] One study described a patient's cognitive function and family adaptation to the patient's illness by using data obtained from three dyads of brain tumor survivors and their mothers[42] [Table 2]. Two patients showed impairments in their cognitive function, although one patient had intact cognition. A mother of the patient with intact cognition indicated positive family adaptation and showed confidence that she could deal with the patient's illness. This patient also described her family as “backbone and support.” In contrast, qualitative data obtained from a patient with impaired cognitive function and her mother showed that they have been struggling to adapt to the patient's illness. Her mother also expressed regret regarding a previous decision about her daughter's treatment and admitted negative family adaptation to her daughter's illness. Contrary to this, the other patient who had significant CI reported positive family adaptation to his illness. His mother even expressed appreciation for the treatment that her son had received and reported that he and his family has been adapting well to his illness. Attitude toward disclosure of the patient's illness refers to a caregiver's position on discussing an illness-related topic with the patient.[45] Some caregivers may show a positive attitude toward discussing disease progression with their patients, but others may not. A study conducted by Kim et al.[45] indicated that patients demonstrated better cognitive function when their family caregivers showed positive attitudes toward disclosure of the illness (P = 0.02). Caregiver burden occurs when caregivers feel overwhelmed as a result of providing care, and this feeling differs from depression, anxiety, and other emotional responses.[46] One study investigated a patient's guilt and concerns that caregiving may interfere with their primary caregivers' life and health (i.e., a patient's self-perceived burden on primary caregiver [SPB-PC]) and its association with a patient's cognitive function. This study showed that a patient's cognitive function can be associated with SPB-PC[47] [Table 2]. For example, greater impairments in cognitive function were reported by patients when SPB-PC was higher (β = 0.211, P = 0.004). Coping is defined as the strategies that caregivers use when caring for their patients;[20] this is often classified as follows: problem-focused, emotion-focused, dysfunctional, or others. One study reported the associations between a patient's cognitive function and caregiver coping[48] [Table 2]. For example, lower incidence of memory problems was noted in patients with cancer when their caregivers used acceptance coping (r = 0.31, P < 0.05). In the same study, authors also investigated a caregiver's resilience, a caregiver's ability to cope with stressors,[49] and examined their associations with a patient's cognitive function. Consistent with previous finding, lower incidence of memory problems was noted when their caregivers were more resiliency (r = −0.30, P < 0.05). Gao et al.[37] examined the associations between cognitive function in patients with advanced cancer and the patients' and caregivers' preferences on the intensity of end-of-life care. In a subanalysis of data from their primary study, they showed a patient's cognitive function was associated with caregiver demographic characteristics, especially their race/ethnicity and relationship with the patient. Patients with advanced cancer tended to demonstrate greater CI when their caregivers were nonwhite [Table 2] (white: Ref, black: OR 2.06, P < 0.04; Hispanic: OR 6.31, P < 0.001) and not a spouse/partner (spouse/partner: Ref, child: OR 2.04, P = 0.04).

Discussion

A total of 10 studies met inclusion criteria and informed this review. Seven categories of caregiver characteristics were identified including mental health, family functioning, adaptation toward the illness, attitude toward disclosure of the illness, burden, coping and resilience, and demographic characteristics. Sixty percent of the studies (n = 6) were designed as cross-sectional, followed by secondary analysis (n = 3) and case study (n = 1). Except for brain cancer group, the included studies (n = 10) showed the significant associations between caregiver characteristics and a patient's cognitive function. This suggests the need to view the patient-caregiver dyad as a unit of care [Figure 2]. The model we adopted from Northouse et al.'s[29] provided a useful framework for understanding the associations between a patient's cognitive function and caregiver characteristics.
Figure 2

A model of the associations between a patient's cognitive function and caregiver characteristics, which was adapted Northouse et al.‘s (2012)

A model of the associations between a patient's cognitive function and caregiver characteristics, which was adapted Northouse et al.‘s (2012) Mental health was the most studied caregiver characteristic that showed an association with a patient's cognitive function. Since none of included studies reported the impact of caregiver mental health on a patient's cognitive function, mental health can be concluded as an associated factor, but not an influencing factor.[36383940] Family functioning reported by caregivers most frequently reported characteristic correlated with patients' cognitive function.[4243] Poor cognitive function was noted when the patient's family members did not function well. Furthermore, caregivers' positive adaptation to the illness[42] and attitude toward disclosures to the patients' illness[45] were also found to be associated with a patient's positive cognitive function. Similarly, positive cognitive function was noted when caregivers were resilient and used certain types of caregiver coping strategies such as acceptance.[48] Conversely, greater patients' CI were found as caregiving burden was higher, which was assessed from the proxy perspective (i.e., patients' perspectives).[47] Finally, caregivers' race/ethnicity and their relationship with the patient (e.g., spouse) were also reported to associate with patients' cognitive function.[37] In this review, the reporting of the results was summarized by associated caregiver characteristics of patients' cognitive function. This information is an essential component of developing dyadic interventions. We found that caregiver's mental health was found to be associated with a patient's cognitive function. This finding indicates that caregiver's mental health is a key characteristic which should be included in interventions offered to the patient-caregiver dyad to improve outcomes of dyads. Both patients with CI and their caregivers would benefit from the intervention to improve caregiver's mental health. These findings also suggest the need for clinicians to assess and monitor caregiver's mental health when they treat a patient's CI. Furthermore, this review paper includes relevant studies across multiple cancer groups and shows an association between a patient's cognitive function and caregiver characteristics. Reviewing caregiver characteristics in relation to cognitive function across a variety of cancer diagnosis allow the identification of a characteristic associated with a certain cancer group versus a characteristic associated across all cancer groups. In turn, this information can be used when creating interventions for each cancer group.

Limitations

Approximately half of included studies did not report confounding factors and did not adjust for these factors (e.g., sociodemographic).[3743454748] This is an important limitation because the associations between caregiver characteristics and a patients' cognitive function could differ depending on confounding factors. Thus, it is important to report and adjust for confounding factors using statistical methods. The result of this review showed varying association between cognitive function and family adaptation to the patient's illness.[42] For example, one patient with intact cognition reported positive family adaptation, and another patient with impaired cognitive function reported negative family adaptation. However, other patients with CIs reported positive family adaptation, which was contradicted by two included cases. This inconsistency may be due to the characteristics of case study research aiming to collect a of variety cases that reflect complex aspects of a certain phenomenon.[50] Although this may limit the understanding of the associations between cognitive function and family caregiver characteristics, we included this study because it showed that they could be related. Another limitation is that all included studies assessed the associations between caregiver characteristics and patient's cognitive function crosssectionally. To fully understand the impact of caregiver characteristics on a patient's cognitive function, alternative designs such as a longitudinal study are needed. We also included the study that assessed patients' self-perceived burden on their caregivers and considered it a substitute (proxy) for caregiver burden.[47] Using a proxy instead of a direct measure is not considered to provide an accurate assessment of a behavior (or concept).[51] However, as this scoping review aimed to explore potential caregiver characteristics associated with a patient's cognitive function, we included this article in our final sample.

Implications

This study indicates that additional research is needed. Specifically, more comprehensive studies are needed to better examine the associations between a patient's cognitive function and caregiver characteristics to guide the development of interventions for adults with cancer who experience impaired cognitive function. CI has been assessed as a condition influenced by the patients themselves; however, this review suggests that patients' CI can also be associated with (or influenced by) outside sources, such as the caregiver's mental health or coping. Since no causal relationship has been identified, future research is warranted to investigate these associations longitudinally. A longitudinal study will provide insights into whether a caregiver's mental health influences the severity of a patient's CI. This understanding will advance the knowledge of cognitive function and be the foundation for more precise and effective dyadic interventions that will improve outcomes for both patients and their caregivers in the context of cognitive function.

Conclusion

This scoping review summarized current evidence concerning caregiver characteristics that are associated with a patient's cognitive function. Of the identified caregiver characteristics, caregivers' mental health was most identified, followed by family functioning, adaptation to the patients' illness, attitude toward disclosure to the patient' illness, burden, coping and resilience, and demographic characteristics. Given these review findings, future research needs to consider the type of measurements and statistical methodologies used when selecting studies. As the number of patients with CI rises, there is a need to concomitantly develop interventions for best practice to support the well-being of this patient population and their caregivers. Enhanced information about CI in relation to caregiver characteristics will eventually provide the foundation for multifocal interventions for patients with impaired cognitive function.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Search strategy

Set numberQuery
Database: PubMed

1“Neoplasms”[Mesh] OR Cancer[tiab] OR cancers[tiab] OR cancerous[tiab] OR neoplasm[tiab] OR neoplasms[tiab]
2“Caregivers”[Mesh] OR cargiver[tiab] OR caregivers[tiab] OR caregiving[tiab] OR “care giver”[tiab] OR “care givers”[tiab] OR “care giving”[tiab] OR carer[tiab] OR carers[tiab]
3“Cognitive Dysfunction”[Mesh] OR “Cognition”[Mesh] OR “Neurodevelopmental Disorders”[Mesh] OR “Executive Function”[Mesh] OR “Cognition Disorders”[Mesh] OR “Attention”[Mesh] OR “Executive Function”[Mesh] OR “Mental Processes”[Mesh] OR “Memory”[Mesh] OR “Spatial Behavior”[Mesh] OR “Psychomotor Performance”[Mesh] OR ((cognition[tiab] OR cognitive[tiab] OR neurocognition[tiab] OR neurocognitive[tiab] OR Neuropsychological[tiab]) AND (disorder[tiab] OR disorders[tiab] OR disability[tiab] OR disabilities[tiab] OR deficiency[tiab] OR deficit[tiab] OR deficits[tiab] OR deficiencies[tiab] OR dysfunction[tiab] OR dysfunctions[tiab] OR impairment[tiab] OR impairments[tiab] OR function[tiab] OR functioning[tiab] OR functions[tiab] OR deterioration[tiab] OR attention[tiab] OR attentions[tiab] OR concentration[tiab] OR concentrations[tiab])) OR “executive function”[tiab] OR “executive functions”[tiab] OR “executive functioning”[tiab] OR “executive control”[tiab] OR “mental processes”[tiab] OR “information processing”[tiab] OR memory[tiab] OR “spatial behavior”[tiab] OR “spatial behaviors”[tiab] OR “spatial learning”[tiab] OR “spatial processing”[tiab] OR “spatial ability”[tiab] OR “spatial abilities”[tiab] OR “psychomotor performance”[tiab] OR “psychomotor ability”[tiab] OR “psychomotor abilities”[tiab] OR “visual motor coordination”[tiab] OR “motor skills”[tiab]
4#1 AND #2 AND #3
5#4 AND English[lang] NOT (animals[mh] NOT humans[mh]) NOT ((“Adolescent”[Mesh] OR “Child”[Mesh] OR “Infant”[Mesh]) NOT “Adult”[Mesh])

Database: CINHAL

1(MH “Neoplasms+”) OR TI (Cancer OR cancers OR cancerous OR neoplasm OR neoplasms) OR AB (Cancer OR cancers OR cancerous OR neoplasms OR carcinoma OR carcinomas OR Oncology OR oncologic)
2(MH “Caregivers”) OR (MH “Caregiver Attitudes”) OR (MH “Caregiver Burden”) OR (MH “Caregiver Support”) OR TI (cargiver OR caregivers OR caregiving OR “care giver” OR “care givers” OR “care giving” OR carer OR carers) OR AB (cargiver OR caregivers OR caregiving OR “care giver” OR “care givers” OR “care giving” OR carer OR carers)
3(MH “Cognition+”) OR (MH “Cognition Disorders+”) OR (MH “Attention+”) OR (MH “Mental Processes+”) OR (MH “Memory+”) OR (MH “Spatial Behavior+”) OR (MH “Psychomotor Performance+”) OR (MH “Executive Function”) OR TI(((cognition OR cognitive OR neurocognition OR neurocognitive OR Neuropsychological) AND (disorder OR disorders OR disability OR disabilities OR deficiency OR deficit OR deficits OR deficiencies OR dysfunction OR dysfunctions OR impairment OR impairments OR function OR functioning OR functions OR deterioration)) OR “executive function” OR “executive functions” OR “executive functioning” OR “executive control” OR “mental processes” OR “information processing” OR memory OR “spatial behavior” OR “spatial behaviors” OR “spatial learning” OR “spatial processing” OR “spatial ability” OR “spatial abilities” OR “psychomotor performance” OR “psychomotor ability” OR “psychomotor abilities” OR “visual motor coordination” OR “motor skills”) OR AB(((cognition OR cognitive OR neurocognition OR neurocognitive OR Neuropsychological) AND (disorder OR disorders OR disability OR disabilities OR deficiency OR deficit OR deficits OR deficiencies OR dysfunction OR dysfunctions OR impairment OR impairments OR function OR functioning OR functions OR deterioration)) OR “executive function” OR “executive functions” OR “executive functioning” OR “executive control” OR “mental processes” OR “information processing” OR memory OR “spatial behavior” OR “spatial behaviors” OR “spatial learning” OR “spatial processing” OR “spatial ability” OR “spatial abilities” OR “psychomotor performance” OR “psychomotor ability” OR “psychomotor abilities” OR “visual motor coordination” OR “motor skills”)
4#1 AND #2 AND #3
5#4 AND LA English and limited to all adult

Database: Embase

1‘neoplasm’/exp OR Cancer: ti, ab OR cancers: ti, ab OR cancerous: ti, ab OR neoplasm: ti, ab OR neoplasms: ti, ab
2‘caregiver’/exp OR cargiver: ti, ab OR caregivers: ti, ab OR caregiving: ti, ab OR ‘care giver’:ti, ab OR ‘care givers’:ti, ab OR ‘care giving’:ti, ab OR carer: ti, ab OR carers: ti, ab
3‘cognition’/de OR ‘executive function’/de OR ‘attention’/de OR ‘mild cognitive impairment’/de OR ‘mental function’/de OR ‘memory’/de OR ‘psychomotor performance’/de OR ‘spatial behavior’/de OR ‘executive function’:ti, ab OR ‘executive functions’:ti, ab OR ‘executive functioning’:ti, ab OR ‘executive control’:ti, ab OR ‘mental processes’:ti, ab OR ‘information processing’:ti, ab OR memory: ti, ab OR ‘spatial behavior’:ti, ab OR ‘spatial behaviors’:ti, ab OR ‘spatial learning’:ti, ab OR ‘spatial processing’:ti, ab OR ‘spatial ability’:ti, ab OR ‘spatial abilities’:ti, ab OR ‘psychomotor performance’:ti, ab OR ‘psychomotor ability’:ti, ab OR ‘psychomotor abilities’:ti, ab OR ‘visual motor coordination’:ti, ab OR ‘motor skills’:ti, ab OR cognition: ti, ab OR ((cognitive: ti, ab OR neurocognition: ti, ab OR neurocognitive: ti, ab OR Neuropsychological: ti, ab) AND (disorder: ti, ab OR disorders: ti, ab OR disability: ti, ab OR disabilities: ti, ab OR deficiency: ti, ab OR deficit: ti, ab OR deficits: ti, ab OR deficiencies: ti, ab OR dysfunction: ti, ab OR dysfunctions: ti, ab OR impairment: ti, ab OR impairments: ti, ab OR function: ti, ab OR functioning: ti, ab OR functions: ti, ab OR deterioration: ti, ab OR attention: ti, ab OR attentions: ti, ab OR concentration: ti, ab OR concentrations: ti, ab))
4#1 AND #2 AND #3
5#4 AND [english]/lim AND ([adult]/lim OR [aged]/lim OR [very elderly]/lim) AND [humans]/lim

Database: PsycINFO

1DE “Neoplasms” OR DE “Benign Neoplasms” OR DE “Breast Neoplasms” OR DE “Endocrine Neoplasms” OR DE “Leukemias” OR DE “Melanoma” OR DE “Metastasis” OR DE “Nervous System Neoplasms” OR DE “Terminal Cancer” OR TI (Cancer OR cancers OR cancerous OR neoplasm OR neoplasms) OR AB (Cancer OR cancers OR cancerous OR neoplasm OR neoplasms)
2(DE “Caregivers”) OR TI (cargiver OR caregivers OR caregiving OR “care giver” OR “care givers” OR “care giving” OR carer OR carers) OR AB (cargiver OR caregivers OR caregiving OR “care giver” OR “care givers” OR “care giving” OR carer OR carers)

Database: PsycINFO

3DE “Cognitive Impairment” OR DE “Cognition” OR DE “Cognitive Ability” OR DE “Spatial Ability” OR DE “Verbal Ability” OR DE “Neurodevelopmental Disorders” OR DE “Disruptive Behavior Disorders” OR DE “Emotional and Behavioral Disorders” OR DE “Learning Disorders” OR DE “Executive Function” OR DE “Cognitive Processes” OR DE “Attention” OR DE “Memory” OR DE “Forgetting” OR DE “Tip of the Tongue Phenomenon” OR DE “Long Term Memory OR DE “Memory Decay” OR DE “Short Term Memory” OR DE “Spatial Memory” OR DE “Verbal Memory” OR DE “Visual Memory” OR DE “Motor Skills” OR TI(((cognition OR cognitive OR neurocognition OR neurocognitive OR Neuropsychological) AND (disorder OR disorders OR disability OR disabilities OR deficiency OR deficit OR deficits OR deficiencies OR dysfunction OR dysfunctions OR impairment OR impairments OR function OR functioning OR functions OR deterioration)) OR “executive function” OR “executive functions” OR “executive functioning” OR “executive control” OR “mental processes” OR “information processing” OR memory OR “spatial behavior” OR “spatial behaviors” OR “spatial learning” OR “spatial processing” OR “spatial ability” OR “spatial abilities” OR “psychomotor performance” OR “psychomotor ability” OR “psychomotor abilities” OR “visual motor coordination” OR “motor skills”) OR AB(((cognition OR cognitive OR neurocognition OR neurocognitive OR Neuropsychological) AND (disorder OR disorders OR disability OR disabilities OR deficiency OR deficit OR deficits OR deficiencies OR dysfunction OR dysfunctions OR impairment OR impairments OR function OR functioning OR functions OR deterioration)) OR “executive function” OR “executive functions” OR “executive functioning” OR “executive control” OR “mental processes” OR “information processing” OR memory OR “spatial behavior” OR “spatial behaviors” OR “spatial learning” OR “spatial processing” OR “spatial ability” OR “spatial abilities” OR “psychomotor performance” OR “psychomotor ability” OR “psychomotor abilities” OR “visual motor coordination” OR “motor skills”)
4#1 AND #2 AND #3
5#4 AND LA English and adult

Database: Scopus

1TITLE-ABS-KEY (Cancer OR cancers OR cancerous OR neoplasm OR neoplasms)
2TITLE-ABS-KEY (cargiver OR caregivers OR caregiving OR “care giver” OR “care givers” OR “care giving” OR carer OR carers)
3 TITLE-ABS-KEY (“executive function” OR “executive functions” OR “executive functioning” OR “executive control” OR “mental processes” OR “information processing” OR memory OR “spatial behavior” OR “spatial behaviors” OR “spatial learning” OR “spatial processing” OR “spatial ability” OR “spatial abilities” OR “psychomotor performance” OR “psychomotor ability” OR “psychomotor abilities” OR “visual motor coordination” OR “motor skills” OR ((cognition OR cognitive OR neurocognition OR neurocognitive OR Neuropsychological) AND (disorder OR disorders OR disability OR disabilities OR deficiency OR deficit OR deficits OR deficiencies OR dysfunction OR dysfunctions OR impairment OR impairments OR function OR functioning OR functions OR deterioration OR attention OR attentions OR concentration OR concentrations))
4#1 AND #2 AND #3
5#4 Limited to English language

Database: Sociological Abstracts

1MAINSUBJECT.EXACT.EXPLODE(“Cancer”) OR TI (Cancer OR cancers OR cancerous OR neoplasm OR neoplasms) OR AB (Cancer OR cancers OR cancerous OR neoplasm OR neoplasms)
2TI (cargiver OR caregivers OR caregiving OR “care giver” OR “care givers” OR “care giving” OR carer OR carers) OR AB (cargiver OR caregivers OR caregiving OR “care giver” OR “care givers” OR “care giving” OR carer OR carers)
3MAINSUBJECT.EXACT.EXPLODE(“Cognition”) OR MAINSUBJECT.EXACT.EXPLODE(“Cognitive Functioning”) OR MAINSUBJECT.EXACT.
EXPLODE(“Attention”) OR MAINSUBJECT.EXACT.EXPLODE(“Memory”) OR MAINSUBJECT.EXACT.EXPLODE(“Spatial Behavior”) OR TI(((cognition OR cognitive OR neurocognition OR neurocognitive OR Neuropsychological) AND (disorder OR disorders OR disability OR disabilities OR deficiency OR deficit OR deficits OR deficiencies OR dysfunction OR dysfunctions OR impairment OR impairments OR function OR functioning OR functions OR deterioration)) OR “executive function” OR “executive functions” OR “executive functioning” OR “executive control” OR “mental processes” OR “information processing” OR memory OR “spatial behavior” OR “spatial behaviors” OR “spatial learning” OR “spatial processing” OR “spatial ability” OR “spatial abilities” OR “psychomotor performance” OR “psychomotor ability” OR “psychomotor abilities” OR “visual motor coordination” OR “motor skills”) OR AB(((cognition OR cognitive OR neurocognition OR neurocognitive OR Neuropsychological) AND (disorder OR disorders OR disability OR disabilities OR deficiency OR deficit OR deficits OR deficiencies OR dysfunction OR dysfunctions OR impairment OR impairments OR function OR functioning OR functions OR deterioration)) OR “executive function” OR “executive functions” OR “executive functioning” OR “executive control” OR “mental processes” OR “information processing” OR memory OR “spatial behavior” OR “spatial behaviors” OR “spatial learning” OR “spatial processing” OR “spatial ability” OR “spatial abilities” OR “psychomotor performance” OR “psychomotor ability” OR “psychomotor abilities” OR “visual motor coordination” OR “motor skills”)
4#1 AND #2 AND #3
5#4 AND LA English

Database: ProQuest Disseration Abstracts

1Exact(“skin cancer” OR “colorectal cancer” OR “esophageal cancer” OR “ovarian cancer” OR “uterine cancer” OR “breast cancer” OR “thyroid cancer” OR “brain cancer” OR “cervical cancer” OR “genital cancers” OR “kidney cancer” OR “lung cancer” OR “testicular cancer” OR “pancreatic cancer” OR “prostate cancer” OR “bone cancer” OR “endometrial cancer” OR “cancer” OR “liver cancer” OR “oral cancer” OR “head & neck cancer”) OR TI (Cancer OR cancers OR cancerous OR neoplasm OR neoplasms) OR AB (Cancer OR cancers OR cancerous OR neoplasm OR neoplasms)
2TI (cargiver OR caregivers OR caregiving OR “care giver” OR “care givers” OR “care giving” OR carer OR carers) OR AB (cargiver OR caregivers OR caregiving OR “care giver” OR “care givers” OR “care giving” OR carer OR carers)

Database: ProQuest Disseration Abstracts

3Exact(“memory” OR “cognition & reasoning” OR “recognition”) OR TI(((cognition OR cognitive OR neurocognition OR neurocognitive OR Neuropsychological) AND (disorder OR disorders OR disability OR disabilities OR deficiency OR deficit OR deficits OR deficiencies OR dysfunction OR dysfunctions OR impairment OR impairments OR function OR functioning OR functions OR deterioration)) OR “executive function” OR “executive functions” OR “executive functioning” OR “executive control” OR “mental processes” OR “information processing” OR memory OR “spatial behavior” OR “spatial behaviors” OR “spatial learning” OR “spatial processing” OR “spatial ability” OR “spatial abilities” OR “psychomotor performance” OR “psychomotor ability” OR “psychomotor abilities” OR “visual motor coordination” OR “motor skills”) OR AB(((cognition OR cognitive OR neurocognition OR neurocognitive OR Neuropsychological) AND (disorder OR disorders OR disability OR disabilities OR deficiency OR deficit OR deficits OR deficiencies OR dysfunction OR dysfunctions OR impairment OR impairments OR function OR functioning OR functions OR deterioration)) OR “executive function” OR “executive functions” OR “executive functioning” OR “executive control” OR “mental processes” OR “information processing” OR memory OR “spatial behavior” OR “spatial behaviors” OR “spatial learning” OR “spatial processing” OR “spatial ability” OR “spatial abilities” OR “psychomotor performance” OR “psychomotor ability” OR “psychomotor abilities” OR “visual motor coordination” OR “motor skills”)
4#1 AND #2 AND #3
5#4 AND LA English
  43 in total

Review 1.  Systematic review of family functioning in families of children and adolescents with chronic pain.

Authors:  Amy S Lewandowski; Tonya M Palermo; Jennifer Stinson; Susannah Handley; Christine T Chambers
Journal:  J Pain       Date:  2010-11       Impact factor: 5.820

2.  Cognitive dysfunction in patients with brain metastases: influences on caregiver resilience and coping.

Authors:  Marlon Garzo Saria; Natasia Courchesne; Lorraine Evangelista; Joshua Carter; Daniel A MacManus; Mary Kay Gorman; Adeline M Nyamathi; Linda R Phillips; David Piccioni; Santosh Kesari; Sally Maliski
Journal:  Support Care Cancer       Date:  2016-12-05       Impact factor: 3.603

3.  Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors.

Authors:  Terence Ng; Sreemanee Raaj Dorajoo; Yin Ting Cheung; Yick Ching Lam; Hui Ling Yeo; Maung Shwe; Yan Xiang Gan; Koon Mian Foo; Wei-Jen Kiley Loh; Si-Lin Koo; Amit Jain; Guek Eng Lee; Rebecca Dent; Yoon Sim Yap; Raymond Ng; Alexandre Chan
Journal:  Psychooncology       Date:  2018-02-01       Impact factor: 3.894

4.  A randomized controlled trial of a brief psychoeducational support group for partners of early stage breast cancer patients.

Authors:  B D Bultz; M Speca; P M Brasher; P H Geggie; S A Page
Journal:  Psychooncology       Date:  2000 Jul-Aug       Impact factor: 3.894

5.  How Does Caregiver Well-Being Relate to Perceived Quality of Care in Patients With Cancer? Exploring Associations and Pathways.

Authors:  Kristin Litzelman; Erin E Kent; Michelle Mollica; Julia H Rowland
Journal:  J Clin Oncol       Date:  2016-10-10       Impact factor: 44.544

6.  Scoping studies: advancing the methodology.

Authors:  Danielle Levac; Heather Colquhoun; Kelly K O'Brien
Journal:  Implement Sci       Date:  2010-09-20       Impact factor: 7.327

7.  Burden of caregivers for patients with mild cognitive impairment in Japan.

Authors:  Satoshi Hayashi; Seishi Terada; Shigeto Nagao; Chikako Ikeda; Aki Shindo; Etsuko Oshima; Osamu Yokota; Yosuke Uchitomi
Journal:  Int Psychogeriatr       Date:  2013-04-19       Impact factor: 3.878

8.  The challenge of quality cancer care for family caregivers.

Authors:  Barbara A Given; Charles W Given; Paula Sherwood
Journal:  Semin Oncol Nurs       Date:  2012-11       Impact factor: 2.315

Review 9.  The impact of caregiving on the psychological well-being of family caregivers and cancer patients.

Authors:  Laurel L Northouse; Maria C Katapodi; Ann M Schafenacker; Denise Weiss
Journal:  Semin Oncol Nurs       Date:  2012-11       Impact factor: 2.315

10.  Cancer- and chemotherapy-related cognitive changes: the patient experience.

Authors:  Jamie S Myers
Journal:  Semin Oncol Nurs       Date:  2013-11       Impact factor: 2.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.